- Home
- ACEL vs TYRA Comparison
ACEL vs TYRA Comparison
Compare ACEL & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- TYRA
- Stock Information
- Founded
- ACEL 2009
- TYRA 2018
- Country
- ACEL United States
- TYRA United States
- Employees
- ACEL N/A
- TYRA N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- ACEL Consumer Discretionary
- TYRA Health Care
- Exchange
- ACEL Nasdaq
- TYRA Nasdaq
- Market Cap
- ACEL 883.4M
- TYRA 844.2M
- IPO Year
- ACEL N/A
- TYRA 2021
- Fundamental
- Price
- ACEL $10.14
- TYRA $14.82
- Analyst Decision
- ACEL Buy
- TYRA Strong Buy
- Analyst Count
- ACEL 1
- TYRA 5
- Target Price
- ACEL $16.00
- TYRA $31.20
- AVG Volume (30 Days)
- ACEL 320.0K
- TYRA 259.7K
- Earning Date
- ACEL 11-04-2025
- TYRA 11-05-2025
- Dividend Yield
- ACEL N/A
- TYRA N/A
- EPS Growth
- ACEL N/A
- TYRA N/A
- EPS
- ACEL 0.50
- TYRA N/A
- Revenue
- ACEL $1,307,029,000.00
- TYRA N/A
- Revenue This Year
- ACEL $9.91
- TYRA N/A
- Revenue Next Year
- ACEL $4.73
- TYRA N/A
- P/E Ratio
- ACEL $20.26
- TYRA N/A
- Revenue Growth
- ACEL 7.97
- TYRA N/A
- 52 Week Low
- ACEL $9.02
- TYRA $6.42
- 52 Week High
- ACEL $13.28
- TYRA $17.78
- Technical
- Relative Strength Index (RSI)
- ACEL 41.49
- TYRA 54.55
- Support Level
- ACEL $9.82
- TYRA $14.54
- Resistance Level
- ACEL $10.58
- TYRA $16.05
- Average True Range (ATR)
- ACEL 0.23
- TYRA 0.81
- MACD
- ACEL -0.00
- TYRA -0.04
- Stochastic Oscillator
- ACEL 42.11
- TYRA 46.52
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.